References
- Aghdassi E, Allard JP. (2000). Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med 28:880–886.
- American Thoracic Society (ATS) and European respiratory Society (ERS). (2005). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171:912–930.
- Berlett BA, Stadtman ER. (1997). Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316.
- California Air Resources Board (CARB). (2007). Air quality data statistics. 2007. Available from: http://www.arb.ca.gov/adam/welcom.html.
- Chinn S. (1991). Statistics in respiratory medicine 2: repeatability and method comparison. Thorax 46:454–456.
- Choi J, Hoffman LA, Rodway GW, Sethi JM. (2006). Markers of lung disease in exhaled breath: nitric oxide. Biol Res Nurs 7:241–255.
- Colman JJ, Swanson AL, Meinardi S, Sive BC, Blake DR, Rowland FS. (2001). Description of the analysis of a wide range of volatile organic compounds in whole air samples collected during PEM-tropics A and B. Analyt Chem 73:3723–3731.
- Cope KA. (2005). Breath ethane in disease: methods for analysis based on room air correction. In: Amann A, Smith D, editors. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. Singapore: World Scientific. p. 237–247.
- Cope KA, Solga SF, Hummers LK, Wigley FM, Diehl AM, Risby TH. (2006). Abnormal exhaled ethane concentrations in scleroderma. Biomarkers 11:70–84.
- Cross CE, Louie S, Kwack S, Wong P, Reddy S, Van Der Vliet A. (2001). Atmospheric oxidants and respiratory tract surfaces. In: Fuchs J, Packer L, editors. Environmental Stressors in Health and Disease. New York: Marcel Dekker Inc. p. 225–236.
- Dillard CJ, Litov RE, Savin WM, Dumelin EE, Tappel AL. (1978). Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. J Appl Physiol 45:927–932.
- Drury JA, Nycyk JA, Cooke RWI. (1997). Pentane measurement in ventilated infants using a commercially available system. Free Radic Biol Med 22:895–900.
- Espinola-Klein C, Rupprecht HJ, Bickel C, Schnabel R, Genth-Zotz S, Torzewski M, Lackner K, Munzel T, Blankenburg S. (2007). Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am J Cardiol 99: 808–812.
- Gustafsson LE. (2005). Exhaled nitric oxide: how and why we know it is important. In: Amann A, Smith D, editors. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. Singapore: World Scientific. p. 103–119.
- Halliwell B, Chirico S. (1993). Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 57 (Suppl.):715S–725S.
- Horvat RJ, Lane WG, Ng H, Shepherd AD. (1964). Saturated hydrocarbons from autoxidizing methyl linoleate. Nature 203:523–524.
- Jöbsis Q, Raatgeep HC, Hop WCJ, de Jongste JC. (2001). Controlled low flow off line sampling of exhaled nitric oxide in children. Thorax 56:285–289.
- Kamboures MA, Blake DR, Cooper DM, Newcomb RL, Barker M, Larson JK, et al. (2005). Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci 102:15762–15767.
- Kanoh S, Kobayashi H, Motoyoshi K. (2005). Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung disease. Chest 128:2387–2392.
- Lärstad MAE, Torén K, Bake B, Olin AC. (2007). Determination of ethane, pentane and isoprene in exhaled air – effects of breath-holding, flow rate and purified air. Acta Physiol 189:87–98.
- Linn WS, Gong H. (2004). Exhaled nitric oxide: sources of error in offline measurements. Arch Environ Health 59:385–391.
- Montuschi P, Nightingale JA, Kharitonov SA, Barnes PJ. (2002). Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radic Biol Med 33:1403–408.
- Packer L. (1995). Oxidative stress, antioxidants, aging and disease. In: Cutler RG, Packer L, Bertram J, Mori A, editors. Oxidative Stress and Aging. Basel: Birkhauser Verlag. p. 1–14.
- Paredi P, Kharitonov SA, Barnes PJ. (2000). Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med 162:1450–1454.
- Phillips M, Greenberg J, Cataneo RN. (2000). Effect of age on the profile of alkanes in normal human breath. Free Radic Res 33:57–63.
- Pryor WA, Godber SS. (1991). Noninvasive measurements of oxidative stress status in humans. Free Radic Biol Med 10:177–184.
- Requena JR, Chao CC, Levine RL, Stadtman ER. (2000). Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins. Proc Natl Acad Sci 98:69–74.
- Ridker PM. (2007). C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis towards consensus. J Am Coll Cardiol 49:2129–2138.
- Seis H. (1985). Oxidative stress: introductory remarks. In: Seis H, editor. Oxidative Stress. London: Academic Press. p. 1–8.
- Sies H. (1986). Biochemistry of oxidative stress. Angewandte Chem Int English Edition 25:1058–1071.
- Sevanian A, Hochstein P. (1985). Mechanisms and consequences of lipid peroxidation in biological systems. Ann Rev Nutr 5:365–390.
- Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. (2005). Exhaled 8-isoprostane in childhood asthma. Respir Res 6:79–84.
- Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, et al. (2006). Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 11:174–183.
- Verbeke B, Molenberghs G. (2001). Linear Mixed Models for Longitudinal Data, 1st edn. New York: Springer.
- Wood LG, Gibson PG, Garg ML. (2003). Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 21:177–186.